Michael L. Krachon
Nessuna posizione attualmente
Profilo
Michael L.
Krachon served as the Chairman of the Coalition For Advancement of Brachytherapy from 2009 to 2016.
He was also a Member of Bard Urological & Medical Division at C.
R.
Bard, Inc. He then served as the Executive Vice President-Sales & Marketing at IsoRay, Inc. from 2020 to 2021.
Krachon received his undergraduate degree from Duke University and his MBA from Goizueta Business School-Emory.
Precedenti posizioni note di Michael L. Krachon
| Società | Posizione | Fine |
|---|---|---|
IsoRay, Inc.
 IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Vendite & Marketing | 12/03/2021 |
| Coalition For Advancement of Brachytherapy | Presidente | 01/01/2016 |
| C.R. BARD | Corporate Officer/Principal | - |
Formazione di Michael L. Krachon
| Duke University | Undergraduate Degree |
| Goizueta Business School-Emory | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
C. R. Bard, Inc. (New Jersey)
 C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology C. R. Bard, Inc. engages in designing, development, manufacturing, packaging, distribution, and sales of medical, surgical, diagnostic, and patient care devices. It sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Franklin Lakes, NJ. | Health Technology |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
| Coalition For Advancement of Brachytherapy | Miscellaneous |
- Borsa valori
- Insiders
- Michael L. Krachon
